An international survey on liver metastases radiotherapy

Acta Oncologica

Volumn 51, Issue 5, 2012, Pages 568-574

  Lock, Michael I ^a   Hoyer, Morten ^b   Bydder, Sean A ^c   Okunieff, Paul ^d   Hahn, Carol A ^e   Vichare, Anushree ^f   Dawson, Laura A ^g  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d UNIVERSITY OF FLORIDA   (United States)

^e DUKE UNIVERSITY   (United States)

^f American Society of Radiation Oncology   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL PRACTICE; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HEALTH SURVEY; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERNATIONAL CLASSIFICATION FOR NURSING PRACTICE; LIVER METASTASIS; LOW DRUG DOSE; MEDICAL SOCIETY; MEDICAL SPECIALIST; ONCOLOGY; ONLINE SYSTEM; PATIENT REFERRAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE;

EVIDENCE-BASED MEDICINE; HEALTH CARE SURVEYS; HUMANS; INTERNATIONAL AGENCIES; LIVER NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; RADIATION ONCOLOGY;

EID: 84862068054     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.681700     Document Type: Review

References (25)

1. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer 2006;106:1624-33.
2. Nordlinger B, Rougier P. Liver metastases from colorectal cancer: The turning point. J Clin Oncol 2002;20:1442-5.
3. Lo SS, Moffatt-Bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, et al. The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 2011;8:405-16.
4. Bydder S, Spry NA, Christie DR, Roos D, Burmeister BH, Krawitz H, et al. A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australas Radiol 2003;47:284-8.
5. Al-Asfoor A, Fedorowicz Z, Lodge M. Resection versus no intervention or other surgical intervention for colorectal cancer liver metastases. Cochrane Database Syst Rev. 2008; 16:CD006039.
6. Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of theRTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 1993;27:117-23.
7. Vickers M, Samson B, Colwell B, Cripps C, Jalink D, El-Sayed S, et al. Eastern Canadian Colorectal Cancer Consensus Conference: Setting the limits of resectable disease. Curr Oncol 2010;17:70-7.
8. Van Cutsem E., Nordlinger B. Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol 2010;21(Suppl 5):v93 - 7.
9. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: Epert consensus statement. Ann Surg Oncol 2006;13: 1271-80.
10. Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, Rougier P, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: Recommendations from an expert panel. Ann Oncol 2009;20:985-92.
11. Berry S, Law C, Vuong T, Chen E, Cripps C, Maroun J, et al. Standards of care for curative surgery and management of metastatic colorectal cancer: Report form the Colorectal Cancer Association of Canada Consensus meeting. Oncol Exchange 2011;10:15-20.
12. Hoyer M, Swaminath A, Bydder S, Lock M, Mendez Romero A, Kavanagh B, et al. Radiotherapy for liver metastases: A review of evidence. Int J Radiat Oncol Biol Phys 2012;82: 1047-57.
13. Dillman D. Mail and telephone surveys. The total design method. 1st ed. New York: Wiley; 1978.
14. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285-8.
15. Vigano A, Donaldson N, Higginson IJ, Bruera E, Mahmud S, Suarez-Almazor M. Quality of life and survival prediction in terminal cancer patients. A multicenter study. Cancer 2004;101:1090-8.
16. Fairchild A, Barnes E, Ghosh S, Ben-Josef E, Roos D, Hartsell W, et al. International patterns of practice in palliative radiotherapy for painful bone metastases: Evidenced based practice? Int J Radiat Oncol Biol Phys 2009;75: 1501-10.
17. McCloskey SA, Tao ML, Rose CM, Fink A, Amadeo AM. National survey of perspectives of palliative radiation therapy: Role, barriers, and needs. Cancer J 2007;13:130-7.
18. W agman R, Youke E, Ford E, Giraud P, Mageras G, Minsky B, et al. Respiratory gating for liver tumors: Use in dose escalation. Int J Radiat Oncol Biol Phys 2003;55: 659-68.
19. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: The report of AAPM Task Group 101. Med Phys 2010; 37:4078-101.
20. Schefter TE, Kavanagh BD. Radiation therapy for liver metastases. Semin Radiat Oncol 2011;21:264-70.
21. Guha C, Kavanagh BD. Hepatic radiation toxicity: Avoidance and amelioration. Semin Radiat Oncol 2011;21: 256-63.
22. Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH, et al. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. In J Radiat Oncol Biol Phys 2005;61:432-43.
23. Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein thrombus. World J Gastroenterol 2006;12:7561-7.
24. Dawson LA. Overview: Where does radiation therapy fi t in the spectrum of liver cancer local-regional therapies? Semin Radiat Oncol 2011;21:241-6.
25. Greco C, Catalano G, Di Grazia A, Orecchia R. Radiotherapy of liver malignancies. From whole liver irradiation to stereotactic hypofractionated radiotherapy. Tumori 2004; 90:73-9.